Breast cancer

Phase 1

Completed

• Conditions: A singled-blinded randomized controlled trial (RCT), pretest-posttest design technique was used to examine the effectiveness of the phone-based support program (PBSP) among women newly diagnosed with breast cancer undergoing chemotherapy.; breast cancer; self-care self-efficacy; psychological well-being; and quality of life

• Registration Number: TCTR20230321010
• Lead Sponsor: /A

Brief Summary

The Phone-Based Support Program showed feasibility and effectiveness in improving self-care self-efficacy, reducing symptom distress, and enhancing quality of life.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-21
• Study Completion: 2023-07-07
• Results First Posted: 2024-02-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 94

Inclusion Criteria

The participants will be recruited through the target population.
The inclusion criteria will be:(1) at least 18 years of age, (2) newly diagnosed as breast cancer with non-metastatic or stage II or lower within the past 3-8 weeks, (3) treated with chemotherapy after surgery at the study sites, (4) be able to access the internet with a mobile phone (5) be contactable via the mobile phone for follow up; and (6) able to communicate Mandarin.

Exclusion Criteria

The exclusion criteria will be: (1) having a concurrent major physical illness, like any physical surgery except for the surgery treatment for breast cancer, injuries or illnesses with the potential for lifelong disability, advanced chronic illness, profound coma, permanent paralysis, or severe brain injury (2) having a chronic mental health problem as diagnoses by a psychiatrist, and (3) unable to complete all session of the implementation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Self-Care Self-Efficacy 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The Self-Care Self-Efficacy Scale

Secondary Outcome Measures

Name	Time	Method
psychological well-being 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The M.D. Anderson Symptom Inventory The Hospital Anxiety and Depression Scale (HADS),quality of life 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) European Organization for Research and Treatment of Cancer QO